Ambulation for Latency During Expectant Management of PPROM
Sponsored by The University of Texas Health Science Center, Houston
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Pregnant women aged 12-55
- Gestational age 23 0/7 to 35 0/7 weeks
- PPROM confirmed by clinical diagnosis which includes sterile speculum examination with pooling, ferning, and nitrazine tests, or the Amnisure ROM Test
- Planned inpatient expectant management with delivery goal >=7 days from enrollment
- Ability to provide informed consent in English or Spanish
Exclusion Criteria
- Imminent delivery
- Transverse or footling breech presentation (if multiple gestation, presenting fetus)
- Unstable lie (if multiple gestation, presenting fetus)
- Funic presentation (if multiple gestation, presenting fetus)
- Active vaginal bleeding
- Regular, painful contractions (>=3 in 10 minutes for 30 minutes or more) consistent with labor
- Clinical contraindication to ambulation as determined by the managing physician
- Physician declines to have the patient approached for participation
- Lethal fetal anomalies